Soluble Prion Peptide 107–120 Protects Neuroblastoma SH-SY5Y Cells against Oligomers Associated with Alzheimer’s Disease
Alzheimer’s disease (AD) is the most prevalent form of dementia and soluble amyloid β (Aβ) oligomers are thought to play a critical role in AD pathogenesis. Cellular prion protein (PrP<sup>C</sup>) is a high-affinity receptor for Aβ oligomers and mediates some of their toxic effects. The...
Main Authors: | Elham Rezvani Boroujeni, Seyed Masoud Hosseini, Giulia Fani, Cristina Cecchi, Fabrizio Chiti |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-10-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/21/19/7273 |
Similar Items
-
The prion-like transmission of tau oligomers via exosomes
by: Noel A. Jackson, et al.
Published: (2022-08-01) -
Cellular Prion Protein as a Receptor of Toxic Amyloid-β42 Oligomers Is Important for Alzheimer’s Disease
by: Yuan Zhang, et al.
Published: (2019-07-01) -
Prion-like seeding and nucleation of intracellular amyloid-β
by: Tomas T. Olsson, et al.
Published: (2018-05-01) -
Anti-β-sheet conformation monoclonal antibody reduces tau and Aβ oligomer pathology in an Alzheimer’s disease model
by: Fernando Goñi, et al.
Published: (2018-01-01) -
Oligomer technology and applications /
by: 247586 Uglea, Constantin V.
Published: (1998)